In this regard, it will be interesting to investigate whether the substrate preference of PLAAT1, which appears to favor the incorporation of saturated fatty acids both in isolated assays and when expressed in cells, will provide some degree of protection from metabolic disorders related to cardiolipin oxidation. This evidence concerns the gene PLAAT1 and metabolic disease.